- Issuer ticker
-
CDIO
- Reported as of
-
23 Jan 2024
- Net transaction value
-
+$1,507,350
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
21 Feb 2024, 14:59:04 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Elisa Luqman as attorney-in-fact for Timur Dogan
Key filing fact
Timur Dogan filed Form 4 for Cardio Diagnostics Holdings, Inc. (CDIO) on 21 Feb 2024.
Key facts
- This page summarizes Timur Dogan's Form 4 filing for Cardio Diagnostics Holdings, Inc. (CDIO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 Feb 2024, 14:59.
Change
- Previous filing in this sequence was filed on 08 Sep 2023.
- Current net transaction value: +$1,507,350.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDIO
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $502,450
- Shares
- +238,128
- Change %
- +121%
- Price
-
$2.11
- Shares after
- 435,467
- Date
- 23 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 238,128
- Exercise price
- $2.11
CDIO
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $1,004,900
- Shares
- +476,256
- Change %
- +50%
- Price
-
$2.11
- Shares after
- 1,433,958
- Date
- 23 Jan 2024
- Ownership
- See note (1)
- Underlying class
- Common Stock
- Underlying amount
- 476,256
- Exercise price
- $2.11
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote